Skip to Content


Russell A. Spivak, I. Glenn Cohen (Faculty Director), and Eli Y. Adashi
Journal of Law and Health
Vol. 30 (2017), Issue 1

Read the Full Article

Abstract:

On December 18, 2015, President Obama signed into law a policy rider forestalling the therapeutic modification of the human germ line. The rider, motivated by the science’s potential unethical ends, is only the most recent instance in which the legislature cut short the ongoing national conversation on the acceptability of a developing science. This essay offers historical perspective on what bills were proposed and passed surrounding four other then-developing scientific breakthroughs—Recombinant DNA, in vitro fertilization, Cloning, Stem Cells—to better analyze how Congress is, and should, regulate this exciting and promising science.

Read the full article here.

Read the Full Article

Tags

bioethics   biotechnology   genetics   health law policy   i. glenn cohen   regulation